Skip to main content

Clinical Effectiveness Group

We are the Clinical Effectiveness Group at Queen Mary University of London.

We use data-driven research and tools to improve population health in North East London and beyond. More about us.


Our collaborative work to reduce strokes in people with atrial fibrillation by increasing the use of life-saving anticoagulant medications has been nominated for an HSJ Patient Safety Award.

CEG-led study finds that more than a quarter of asthma patients are still over-using inhalers intended for rapid relief of symptoms. Overuse of these inhalers is linked to an increased risk of hospital admissions and severe asthma attacks.

We are monitoring Covid-19 vaccination across North East London, from Clinical Commissioning Group to practice-level. Our searches and tools are supporting GPs through the programme and with the ongoing care of all patients. For advice, contact us at